NEW YORK, Aug. 27 The American Stock Exchange(R) (Amex(R))today lists the common stock of Neuralstem, Inc. under the ticker symbol CUR.
Neuralstem, Inc. is a biotechnology company focused on developing andcommercializing human neural stem cell technology in the field of regenerativemedicine.
"We proudly welcome Neuralstem to the American Stock Exchange," said JohnMcGonegal, Senior Vice President of Amex's Equities Group. "Many biotechnologycompanies have chosen to list at the Amex this year and we are pleased thatNeuralstem is the latest company to recognize our expanding presence in thisimportant sector."
"Moving to the Amex is the next logical step for Neuralstem. It is aresult of the continuous and significant progress the company has made in eachand every phase of its activity, and of an increasing awareness of the companyand its prospects on the part of the financial community," said Richard Garr,Neuralstem President and Chief Executive Officer.
The specialist for Neuralstem, Inc. will be Cohen Specialist LLC. Forfurther information on CUR and other Amex-listed companies, please visitwww.amex.com.
About American Stock Exchange
The American Stock Exchange(R) (Amex(R)) offers trading across a fullrange of equities, options and exchange traded funds (ETFs), includingstructured products and HOLDRS(SM). In addition to its role as a nationalequities market, the Amex is the pioneer of the ETF, responsible for bringingthe first domestic product to market in 1993. Leading the industry in ETFlistings, the Amex lists 337 ETFs to date. The Amex is also one of the largestoptions exchanges in the U.S., trading options on broad-based and sectorindexes as well as domestic and foreign stocks. For more information, pleasevisit www.amex.com
SOURCE American Stock Exchange